578 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Acquired by Client 1ST Advisory Group LLC

Client 1ST Advisory Group LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 578 shares of the healthcare conglomerate's stock, valued at approximately $292,000.

A number of other large investors also recently modified their holdings of UNH. Delta Financial Group Inc. raised its position in shares of UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate's stock worth $965,000 after acquiring an additional 17 shares during the last quarter. First PREMIER Bank grew its position in shares of UnitedHealth Group by 7.0% during the 3rd quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate's stock worth $160,000 after buying an additional 18 shares during the period. Genesee Capital Advisors LLC boosted its stake in UnitedHealth Group by 1.9% in the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate's stock valued at $579,000 after acquiring an additional 18 shares during the last quarter. Jmac Enterprises LLC lifted its stake in shares of UnitedHealth Group by 2.2% in the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate's stock valued at $481,000 after purchasing an additional 18 shares during the period. Finally, Matrix Private Capital Group LLC grew its stake in shares of UnitedHealth Group by 3.6% during the second quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate's stock worth $276,000 after purchasing an additional 19 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on UNH. Oppenheimer upped their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. Bank of America lowered their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a research report on Wednesday, October 16th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective on the stock in a report on Friday, January 10th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Finally, Truist Financial cut their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Two investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of "Buy" and a consensus target price of $627.74.

UnitedHealth Group Stock Down 0.1 %

Shares of NYSE:UNH traded down $0.56 during midday trading on Monday, hitting $510.03. The stock had a trading volume of 7,462,712 shares, compared to its average volume of 5,104,531. The company has a market cap of $469.37 billion, a P/E ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The business's 50-day simple moving average is $549.37 and its 200-day simple moving average is $563.70. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group's revenue was up 6.8% on a year-over-year basis. During the same period last year, the business posted $5.83 EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group's payout ratio is presently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.